Ambulatory medicament pumps with selective alarm muting
Abstract
Ambulatory medicament devices that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and methods can implement one or more features that improve the user experience, by modifying delivery of therapy to a subject after determining that a possible occlusion exists in a medicament delivery system, monitoring the status of an ambulatory medical device and the health condition of a subject that receives therapy from the ambulatory medical device and annunciating alarm condition when necessary, selectively muting alarm annunciations while a Do Not Disturb mode is activated, implementing various power saving modes to save power, controlling operation of the device and medicament delivery based on the user gesture controls, and controlling medicament delivery based on a condition of the ambulatory medicament device.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An ambulatory medicament device configured to maintain indications of alarm conditions on a list of pending alarm conditions without auditory or haptic annunciation of at least some of the alarm conditions while a do not disturb mode is active, the ambulatory medicament device comprising:
a monitoring system interface configured to receive status information, wherein the status information comprises at least one of device information pertaining to a condition of the ambulatory medicament device or subject information pertaining to a condition of a subject; a memory configured to store specific computer-executable instructions and the list of pending alarm conditions; and a hardware processor in communication with the memory and configured to execute the specific computer-executable instructions to at least:
receive alarm muting instructions via user interaction with an alarm muting control interface;
in response to determining that alarm annunciation should be muted in accordance with the alarm muting instructions, activate the do not disturb mode of the ambulatory medicament device, wherein at least some alarm annunciation patterns are not aurally or haptically annunciated while the ambulatory medicament device is in the do not disturb mode;
detect, via the monitoring system interface, that the status information or the subject information indicates at least one of a first alarm condition, a second alarm condition, or a third alarm condition;
determine that the first alarm condition requires urgent user attention;
in response to determining that the first alarm condition requires urgent user attention, annunciate the first alarm condition, without deactivating the do not disturb mode, using a first alarm condition annunciation pattern comprising at least one of auditory or haptic annunciation;
maintain an indication of the first alarm condition on the list of pending alarm conditions until the first alarm condition is resolved;
determine that the second alarm condition does not require urgent user attention;
in response to determining that the second alarm condition does not require urgent user attention, maintain an indication of the second alarm condition on the list of pending alarm conditions until the second alarm condition is resolved without auditory or haptic annunciation of the second alarm condition while the do not disturb mode is active;
determine that the third alarm condition does not require urgent user attention and that the third alarm condition has lower priority than the second alarm condition; and
upon deactivation of the do not disturb mode, annunciate the second alarm condition without auditory or haptic annunciation of the third alarm condition.
2 . The ambulatory medicament device of claim 1 , wherein the hardware processor is configured to execute further computer-executable instructions to, in response to determining that the first alarm condition requires urgent user attention, deactivate the do not disturb mode.
3 . The ambulatory medicament device of claim 1 , wherein determining that the first alarm condition requires urgent user attention comprises:
determining a severity level of the first alarm condition; and determining that the severity level of the first alarm condition exceeds a threshold severity level.
4 . The ambulatory medicament device of claim 1 , wherein the alarm muting control interface comprises a touchscreen controller configured to output display signals configured to generate user interface screens on a touchscreen and to receive user input signals corresponding to user interaction with the touchscreen.
5 . The ambulatory medicament device of claim 1 , wherein the alarm muting instructions comprise a recurring time interval, wherein the hardware processor is configured to execute further computer-executable instructions to activate the do not disturb mode during the recurring time interval.
6 . The ambulatory medicament device of claim 5 , wherein the recurring time interval comprises a time interval occurring every day between 18:00 and 07:00.
7 . The ambulatory medicament device of claim 1 , wherein the alarm muting control interface is part of a remote device that is separate from the ambulatory medicament device.
8 . The ambulatory medicament device of claim 1 , wherein the list of pending alarm conditions is sorted according to severity levels of alarm conditions included on the list of pending alarm conditions.
9 . The ambulatory medicament device of claim 1 , wherein the list of pending alarm conditions is displayed on a user interface of the ambulatory medicament device.
10 . The ambulatory medicament device of claim 9 , wherein the list of pending alarm conditions comprises alarm status indicators, wherein the alarm status indicators indicate whether pending alarm conditions in the list of pending alarm conditions were annunciated or muted.
11 . The ambulatory medicament device of claim 1 , wherein the alarm muting instructions comprise a time period during which the do not disturb mode is to remain active, wherein the hardware processor is configured to execute further computer-executable instructions to deactivate the do not disturb mode after the time period has passed.
12 . The ambulatory medicament device of claim 11 , wherein the hardware processor is configured to execute further computer-executable instructions to:
receive via user interaction with the alarm muting control interface, prior to termination of the time period, instructions to deactivate the do not disturb mode; and deactivate the do not disturb mode.
13 . The ambulatory medicament device of claim 1 , wherein the hardware processor is configured to execute further computer-executable instructions to:
determine the second alarm condition has not been resolved for a threshold amount of time; escalate the second alarm condition such that the second alarm condition requires urgent user attention; and in response to determining that the second alarm condition requires urgent user attention, annunciate the second alarm condition using a second alarm condition annunciation pattern comprising at least one of auditory or haptic annunciation.
14 . The ambulatory medicament device of claim 1 wherein resolving alarm conditions comprises at least one of: correcting the alarm conditions, acknowledging the alarm conditions, or snoozing the alarm conditions.
15 . The ambulatory medicament device of claim 14 , wherein correcting the alarm conditions comprises one or more actions taken by a user that address a condition which caused an alarm to be generated.
16 . The ambulatory medicament device of claim 1 , wherein the first alarm condition is resolved automatically when the status information or the subject information no longer indicates the first alarm condition.
17 . The ambulatory medicament device of claim 1 , wherein the hardware processor is configured to execute further computer-executable instructions to maintain an indication of the third alarm condition on the list of pending alarm conditions until the third alarm condition is resolved without auditory or haptic annunciation of the third alarm condition.
18 . A glucose control system comprising:
a monitoring system interface configured to receive status information, wherein the status information comprises at least one of device information pertaining to a condition of the glucose control system or subject information pertaining to a condition of a subject; a memory configured to store specific computer-executable instructions and a list of pending alarm conditions; and a hardware processor in communication with the memory and configured to execute the specific computer-executable instructions to at least:
receive alarm muting instructions via user interaction with an alarm muting control interface;
in response to determining that alarm annunciation should be muted in accordance with the alarm muting instructions, activate a do not disturb mode of the glucose control system, wherein at least some alarm annunciation patterns are muted while the glucose control system is in the do not disturb mode;
detect, via the monitoring system interface, that the status information or the subject information indicates an alarm condition;
determine that the alarm condition does not require urgent user attention; and
in response to determining that the alarm condition does not require urgent user attention, maintain an indication of the alarm condition on the list of pending alarm conditions until the alarm condition is resolved without auditory or haptic annunciation of the alarm condition while the do not disturb mode is active.
19 . The glucose control system of claim 18 , wherein the list of pending alarm conditions is sorted according to severity levels of alarm conditions included on the list of pending alarm conditions.
20 . The glucose control system of claim 19 , wherein the hardware processor is configured to execute further computer-executable instructions to, upon deactivation of the do not disturb mode, annunciate a most severe alarm condition, based on the severity levels of the alarm conditions included on the list of pending alarm conditions.
21 . The glucose control system of claim 18 , wherein the hardware processor is configured to execute further computer-executable instructions to:
detect, via the monitoring system interface, a second alarm condition; determine that the second alarm condition requires urgent user attention; and in response to determining that the second alarm condition requires urgent user attention, deactivate the do not disturb mode.
22 . The glucose control system of claim 18 , wherein the hardware processor is configured to execute further computer-executable instructions to:
detect, via the monitoring system interface, a second alarm condition; determine that the second alarm condition requires urgent user attention; and in response to determining that the second alarm condition requires urgent user attention, annunciate the second alarm condition without deactivating the do not disturb mode, using a second alarm condition annunciation pattern comprising at least one of auditory or haptic annunciation.
23 . The glucose control system of claim 18 , wherein the list of pending alarm conditions comprises alarm status indicators, wherein the alarm status indicators indicate whether pending alarm conditions in the list of pending alarm conditions were annunciated or muted.
24 . The glucose control system of claim 18 , wherein the alarm muting control interface comprises a touchscreen controller configured to output display signals configured to generate user interface screens on a touchscreen and to receive user input signals corresponding to user interaction with the touchscreen.
25 . A method of annunciating alarms associated with a glucose control system, the method comprising:
receiving alarm muting instructions via user interaction with an alarm muting control interface; in response to determining that alarm annunciation should be muted in accordance with the alarm muting instructions, activating a do not disturb mode of the glucose control system, wherein at least some alarm annunciation patterns are muted while the glucose control system is in the do not disturb mode; detecting that an alarm condition exists; determining that the alarm condition does not require urgent user attention; and in response to determining that the alarm condition does not require urgent user attention, maintain an indication of the alarm condition on a list of pending alarm conditions until the alarm condition is resolved without auditory or haptic annunciation of the alarm condition while the do not disturb mode is active.
26 . The method of claim 25 , wherein detecting that an alarm condition exists comprises detecting that at least one of device information pertaining to a condition of the glucose control system or subject information pertaining to a condition of a subject indicates an alarm condition.
27 . The method of claim 25 , wherein receiving the alarm muting instructions comprises receiving, via user interaction with the alarm muting control interface, a time period during which the do not disturb mode is to remain active.
28 . The method of claim 27 , further comprising:
receiving, via user interaction with the alarm muting control interface, prior to termination of the time period, instructions to deactivate the do not disturb mode; and deactivating the do not disturb mode.
29 . The method of claim 25 , further comprising:
detecting a second alarm condition; determining that the second alarm condition requires urgent user attention; and in response to determining that the second alarm condition requires urgent user attention, deactivating the do not disturb mode.
30 . The method of claim 25 , further comprising:
detecting a second alarm condition; determining that the second alarm condition requires urgent user attention; and in response to determining that the second alarm condition requires urgent user attention, annunciating the second alarm condition without deactivating the do not disturb mode, using a second alarm condition annunciation pattern comprising at least one of auditory or haptic annunciation.Join the waitlist — get patent alerts
Track US2022265143A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.